On this page
Pegintron
peginterferon alfa-2b
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Pegintron
Proper name
peginterferon alfa-2b
Licence type
351(a)
BLA number
103949
Applicant
Merck Sharp & Dohme LLC
Center
CDER
Presentations
8
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 120MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Disc | January 19, 2001 |
| 120MCG/0.5ML | Injection | Subcutaneous | Single-Dose Vial | Disc | January 19, 2001 |
| 150MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Disc | January 19, 2001 |
| 150MCG/0.5ML | Injection | Subcutaneous | Single-Dose Vial | Disc | January 19, 2001 |
| 50MCG/0.5ML | Injection | Subcutaneous | Single-Dose Vial | Disc | January 19, 2001 |
| 50MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Disc | January 19, 2001 |
| 80MCG/0.5ML | Injection | Subcutaneous | Autoinjector | Disc | January 19, 2001 |
| 80MCG/0.5ML | Injection | Subcutaneous | Single-Dose Vial | Disc | January 19, 2001 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |